Guangya Xua,
Bin Lia,
Ting Wanga,
Jun Wana,
Yan Zhanga,
Jingwei Huanga and
Yangmei Shen*bc
aDepartment of Anatomical Pathology and Pathophysiology, College of Medicine, Chengdu University, Chengdu, People’s Republic of China
bDepartment of Pathology, West China Second University Hospital, Sichuan University, Chengdu, 610041, PR China. E-mail: symjulia@126.com; Fax: +86 2885164060; Tel: +86 2885164063
cKey Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, 610041, PR China
First published on 16th October 2019
Correction for ‘Enhancing the anti-ovarian cancer activity of quercetin using a self-assembling micelle and thermosensitive hydrogel drug delivery system’ by Guangya Xu et al., RSC Adv., 2018, 8, 21229–21242.
In addition, on page 21237 of the original manuscript in the section titled “3.3.4 Induction of tumor cell apoptosis in vivo”, a sentence should be corrected. “The apoptotic index in Qu-M–hydrogel composites, Qu-M, free quercetin (Free-Qu), empty hydrogel and normal saline (NS) were 72.7% ± 6.34%, 43.23% ± 4.68%, 28.23% ± 3.23%, 2.14% ± 0.57%, and 1.31% ± 0.43, respectively,” should be “The apoptotic index in Qu-M–hydrogel composites, Qu-M, free quercetin (Free-Qu), empty hydrogel and normal saline (NS) were 72.7% ± 6.34%, 43.23% ± 4.68%, 23.41% ± 5.37%, 2.14% ± 0.57%, and 1.52% ± 0.35, respectively”.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2019 |